STATENS ARBEIDSMILJOINSTITUTT

Their core work

STAMI is Norway's National Institute of Occupational Health, conducting research on how workplace exposures affect human health. Their H2020 work focuses on two interlinked domains: assessing the safety and health risks of nanomaterials (in both industrial and medical settings), and mapping occupational exposures that lead to chronic disease. They bring epidemiological expertise, exposure assessment methods, and toxicological testing capabilities to European research consortia studying how engineered and environmental particles interact with the human body.

What they specialise in

How they've shifted over time

STAMI's early H2020 involvement (2016–2019) centered on nanotechnology safety — understanding hazards of engineered nanomaterials and ensuring safe use in medical technologies. From 2020 onward, their focus broadened significantly toward the human exposome: large-scale occupational health studies using omics, cohort data, and sensor-based monitoring, plus the emerging concern of microplastics in the human body. The trajectory shows a shift from material-specific toxicology toward systemic, data-intensive health surveillance.

STAMI is moving toward large-scale, data-driven occupational health research combining sensor technologies, omics, and epidemiological cohorts — making them a strong partner for future projects on workplace health monitoring and environmental contaminant exposure.

How they like to work

STAMI participates exclusively as a consortium partner, never leading as coordinator, which suggests they contribute specialized occupational health and toxicology expertise to projects led by others. With 90 unique partners across 21 countries from just 4 projects, they operate in large, diverse consortia — typical for major EU health and safety research initiatives. This makes them an accessible and experienced consortium member who integrates smoothly into multi-partner projects.

Despite only 4 H2020 projects, STAMI has built a broad network of 90 unique partners across 21 countries, reflecting their participation in large pan-European research consortia. Their reach spans most of the EU and associated countries, with no narrow geographic clustering.

What sets them apart

STAMI sits at a rare intersection: they combine occupational health epidemiology with nanotoxicology and emerging contaminant research (microplastics), all under one institutional roof. As a national institute rather than a university lab, they have long-running access to Norwegian worker cohort data and exposure registries that are difficult to replicate. For consortium builders, STAMI offers both the regulatory credibility of a government research body and hands-on expertise in human exposure assessment.

Highlights from their portfolio

• EPHOR
  Their largest project (EUR 830K), tackling the full occupational exposome with an ambitious mix of cohort studies, sensors, omics, and job exposure matrices.
• PlasticsFatE
  Addresses the rapidly growing concern of micro- and nano-plastics in the human body — a topic with high public and regulatory relevance.
• SAFE-N-MEDTECH
  Bridges nanotechnology with medical device regulation, covering the full safety lifecycle of nano-enabled health technologies.